Outcomes for Juvenile idiopathic arthritis

Paediatrics and Child Health (United Kingdom)

Volumn 24, Issue 2, 2014, Pages 64-71

  Armon, Kate ^a  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Arthritis; Child; Juvenile idiopathic arthritis; Outcome s

Indexed keywords

METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; TRIAMCINOLONE HEXACETONIDE;

ARTHROPLASTY; BIOLOGICAL THERAPY; CHILD HEALTH ASSESSMENT QUESTIONNAIRE; CHILDHOOD DISEASE; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISABILITY; DISEASE ACTIVITY; DISEASE CLASSIFICATION; EMPLOYMENT; GROWTH DISORDER; HEALTH ASSESSMENT QUESTIONNAIRE; HEALTH EDUCATION; HUMAN; JOINT DESTRUCTION; JOINT RADIOGRAPHY; JUVENILE ARTHRITIS DAMAGE INDEX; JUVENILE RHEUMATOID ARTHRITIS; MENTAL HEALTH; MONITORING; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTCOME ASSESSMENT; PAIN; PATHOPHYSIOLOGY; QUALITY OF LIFE; RELAPSE; REMISSION; REVIEW; SYSTEMIC THERAPY; UVEITIS;

EID: 84892981659     PISSN: 17517222     EISSN: 1878206X     Source Type: Journal    
DOI: 10.1016/j.paed.2013.07.008     Document Type: Review

References (14)

1. Arthritis Research UK. useful patient information and the PGALS DVD available. http://www.arthritisresearchuk.org.
2. British Society for paediatric and adolescent rheumatology. http://www.bspar.org.uk.
3. British Society for Paediatric and Adolescent Rheumatology. UK guidelines on medication, link to NICE guidelines, CHAQ and scoring available. ARMA/BSPAR Standards of Care. http://www.bspar.org.uk.
4. Carrasco R., Cobb J., Baildom E., et al. Predictors of disability in children with inflammatory arthritis, two and three years after first presentation to paediatric rheumatology. Results form the childhood arthritis prospective study (CAPS). Pediatr Rheumatol 2011, 9. 1546-0096.
5. Consolaro A., Negro G., Solari N., et al. Targeting remission in juvenile arthritis in routine clinical care: experience in 175 newly-diagnosed patients. Arthritis Rheum 2012, 64(S503):4-3591.
6. Lorati A., Salmaso A., Gerloni V., Gattinara M., Fantini F. Accuracy of Wallace criteria for clinical remission in juvenile idiopathic arthritis: a cohort study of 761 consecutive cases. J Rheumatol 2009, 36/7:1532-1535.
7. Lovell D.J., Giannini E.H., Reiff A., et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. N Engl J Med 2000, 342:763-800.
8. NICE Guidance on the use of etanercept for the treatment of juvenile idiopathic arthritis March 2002, Ref. N0070. http://www.nice.org.uk.
9. Oen K., Malleson P.N., Cabral D.A., Rosenberg A.M., Petty R.E., Cheang M. Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort. J Rheumatol 2002, 29:1989-1999.
10. Packham J.C., Hall M.A. Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcome. Rheumatology 2002, 41:1428-1435.
11. Paediatric Rheumatology European Society. http://www.pres.org.uk/.
12. Paediatric Rheumatology International Trials Organisation. good information for families and resources for research activity. http://www.printo.it/.
13. Petty R.E., Southwood T.R., Manners P., et al. International League of Associations for Rheumatology classification of juvenile arthritis: second revision, Edmonton, 2001. J Rheumatol 2004, 31:390-392.
14. Tse S.M.L., Tucker L.B., Chedeville G., et al. Two year remission rates and functional outcomes in an inception cohort of Canadian children with juvenile idiopathic arthritis. Pediatr Rheumatol 2012, 10. 1546-0096.